Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
Authors
Keywords
-
Journal
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 42, Issue 6, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-04-14
DOI
10.1161/atv.0000000000000153
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic pipeline in nonalcoholic steatohepatitis
- (2021) Raj Vuppalanchi et al. Nature Reviews Gastroenterology & Hepatology
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of bariatric surgery in the management of nonalcoholic steatohepatitis
- (2021) Keri A. Seymour et al. CURRENT OPINION IN GASTROENTEROLOGY
- Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort
- (2021) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Bariatric surgery and the liver—Mechanisms, benefits, and risks
- (2021) Sander Lefere et al. Obesity Reviews
- Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis
- (2021) Miller Barreto de Brito e Silva et al. OBESITY SURGERY
- A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
- (2021) Sven M. Francque et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
- (2021) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypobetalipoproteinemia and abetalipoproteinemia
- (2020) Francine K. Welty CURRENT OPINION IN LIPIDOLOGY
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Bariatric Surgery Decreases the Progression of Nonalcoholic Fatty Liver Disease to Cirrhosis
- (2020) Andrew M. Brown et al. ANNALS OF SURGERY
- Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis
- (2020) Yasaman Vali et al. JOURNAL OF HEPATOLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- From NAFLD to MAFLD: Implications of a premature change in terminology
- (2020) Zobair M Younossi et al. HEPATOLOGY
- Improvement of the 10-Year Atherosclerotic Cardiovascular Disease (ASCVD) Risk Following Bariatric Surgery
- (2020) Guillermo Ponce de León-Ballesteros et al. OBESITY SURGERY
- NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
- (2020) Amélio F. Godoy-Matos et al. Diabetology & Metabolic Syndrome
- Benefits and Risks of Bariatric Surgery in Adults
- (2020) David E. Arterburn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
- (2019) Connie B. Newman et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2019) Scott M. Grundy et al. CIRCULATION
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- The Beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content
- (2019) Yftach Gepner et al. JOURNAL OF HEPATOLOGY
- The negative and detrimental effects of high fructose on the liver, with special reference to metabolic disorders
- (2019) Brandon H Mai et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement
- (2019) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis
- (2019) Yan Liu et al. Scientific Reports
- Nonalcoholic Fatty Liver Disease and the Incidence of Myocardial Infarction: A Cohort Study
- (2019) Dong Hyun Sinn et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Are Lifestyle Therapies Effective for NAFLD Treatment?
- (2019) Nermeen N. El-Agroudy et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design
- (2019) Quentin M. Anstee et al. Contemporary Clinical Trials
- Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
- (2019) Gordon I. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
- (2019) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
- (2018) David Højland Ipsen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis
- (2018) Veeral Ajmera et al. Clinical Gastroenterology and Hepatology
- Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes
- (2018) Fernando Bril et al. Clinical Gastroenterology and Hepatology
- Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk
- (2018) Vasilios G. Athyros et al. Current Vascular Pharmacology
- Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease
- (2018) Yao-Yao Zhou et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study
- (2018) Alina M. Allen et al. HEPATOLOGY
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
- (2018) Noura S. Abul-Husn et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis
- (2018) Marina Kawaguchi-Suzuki et al. Frontiers in Pharmacology
- Relationship between fatty liver, specific and multiple-site atherosclerosis and 10-year Framingham Score
- (2018) Raluca Pais et al. HEPATOLOGY
- Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
- (2018) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver disease
- (2018) Mitchell Shiffman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- Treatment of NAFLD with diet, physical activity and exercise
- (2017) Manuel Romero-Gómez et al. JOURNAL OF HEPATOLOGY
- The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms
- (2017) Shira Zelber-Sagi et al. LIVER INTERNATIONAL
- Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease
- (2017) Hashimoto Yoshitaka et al. MEDICINE
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current and emerging pharmacological therapy for non-alcoholic fatty liver disease
- (2017) Ahad Eshraghian WORLD JOURNAL OF GASTROENTEROLOGY
- Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis
- (2017) A. L. L. Rocha et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Nonalcoholic Fatty Liver Disease in Latinos
- (2016) Sammy Saab et al. Clinical Gastroenterology and Hepatology
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes
- (2016) Alessandro Mantovani et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Fatty liver is an independent predictor of early carotid atherosclerosis
- (2016) Raluca Pais et al. JOURNAL OF HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD)
- (2016) Ratree Sawangjit et al. MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)
- (2015) Mahmoud Al Rifai et al. ATHEROSCLEROSIS
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study
- (2015) Vincent Wai-Sun Wong et al. HEPATOLOGY
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study
- (2015) Jessica L. Mellinger et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
- (2015) Erin K. Spengler et al. MAYO CLINIC PROCEEDINGS
- Emerging Liver–Kidney Interactions in Nonalcoholic Fatty Liver Disease
- (2015) Giovanni Musso et al. TRENDS IN MOLECULAR MEDICINE
- Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis
- (2014) Yang Jiao et al. ACTA PHARMACOLOGICA SINICA
- Ectopic Fat, Insulin Resistance, and Nonalcoholic Fatty Liver Disease
- (2014) Christopher D. Byrne et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lomitapide and Mipomersen
- (2014) Daniel J. Rader et al. CIRCULATION
- PCSK9
- (2014) Nabil G. Seidah et al. CIRCULATION RESEARCH
- NAFLD prevalence differs among hispanic subgroups: The multi-ethnic study of atherosclerosis
- (2014) Michael Wayne Fleischman WORLD JOURNAL OF GASTROENTEROLOGY
- Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis
- (2014) Juan Du WORLD JOURNAL OF GASTROENTEROLOGY
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2014) Giovanni Musso et al. PLOS MEDICINE
- Cholic acid for hepatic steatosis in patients with lipodystrophy: a randomized, controlled trial
- (2013) Zahid Ahmad et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels
- (2013) Matti J. Tikkanen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Hepatic stellate cells in liver development, regeneration, and cancer
- (2013) Chunyue Yin et al. JOURNAL OF CLINICAL INVESTIGATION
- The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
- (2013) Marno C. Ryan et al. JOURNAL OF HEPATOLOGY
- The liver diseases of lipodystrophy: The long-term effect of leptin treatment
- (2013) Elika Safar Zadeh et al. JOURNAL OF HEPATOLOGY
- Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial
- (2013) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- Racial differences in nonalcoholic fatty liver disease in the U.S. population
- (2013) Andrea L. C. Schneider et al. Obesity
- Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population
- (2012) Maria Stepanova et al. Clinical Gastroenterology and Hepatology
- Tumor Necrosis Factor-α Signaling in Macrophages
- (2012) Narayanan Parameswaran et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Nonalcoholic fatty liver disease is associated with coronary artery calcification
- (2012) Donghee Kim et al. HEPATOLOGY
- Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism
- (2012) Claudia O. Zein et al. HEPATOLOGY
- Molecular mechanism of alcoholic fatty liver
- (2012) Karuna Rasineni et al. INDIAN JOURNAL OF PHARMACOLOGY
- Health Benefits of Gastric Bypass Surgery After 6 Years
- (2012) Ted D. Adams et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epicardial Steatosis, Insulin Resistance, and Coronary Artery Disease
- (2012) Peter P. Toth Heart Failure Clinics
- Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease
- (2011) V. W.-S. Wong et al. GUT
- Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
- (2011) Claudia O. Zein et al. HEPATOLOGY
- Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial
- (2011) Dawn M. Torres et al. HEPATOLOGY
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vitamin E and the Risk of Prostate Cancer
- (2011) Eric A. Klein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Natural course of nonalcoholic fatty liver disease in southern China: A prospective cohort study
- (2011) Yong Jian ZHOU et al. Journal of Digestive Diseases
- Ultrasonographic Quantitative Estimation of Hepatic Steatosis in Children With NAFLD
- (2011) Angela Shannon et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Pioglitazone in the treatment of NASH: the role of adiponectin
- (2010) A. Gastaldelli et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Relationship between Kidney Function and Liver Histology in Subjects with Nonalcoholic Steatohepatitis
- (2010) G. Targher et al. Clinical Journal of the American Society of Nephrology
- Insulin Resistance in Nonalcoholic Fatty Liver Disease
- (2010) E. Bugianesi et al. CURRENT PHARMACEUTICAL DESIGN
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- (2010) Christopher D. Williams et al. GASTROENTEROLOGY
- Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease
- (2010) Manal F. Abdelmalek et al. HEPATOLOGY
- Non-invasive assessment of hepatic steatosis: Prospective comparison of the accuracy of imaging examinations
- (2010) Seung Soo Lee et al. JOURNAL OF HEPATOLOGY
- Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
- (2010) Vasilios G Athyros et al. LANCET
- Nonalcoholic steatohepatitis and increased risk of chronic kidney disease
- (2010) Kohichiroh Yasui et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of Hepatic Steatosis in Patients Undergoing Liver Resection: Comparison of US, CT, T1-weighted Dual-Echo MR Imaging, and Point-resolved1H MR Spectroscopy
- (2010) Jochem R. van Werven et al. RADIOLOGY
- Presence of Coronary Plaques in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Nimer Assy et al. RADIOLOGY
- Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)
- (2010) Noreen Hossain et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis
- (2009) Wing-Kin Syn et al. Clinics in Liver Disease
- Association Between Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification
- (2009) Chien-Hua Chen et al. DIGESTIVE DISEASES AND SCIENCES
- Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels
- (2009) Robin Haring et al. HEPATOLOGY
- Apoptotic Markers Indicate Nonalcoholic Steatohepatitis in Polycystic Ovary Syndrome
- (2009) Susanne Tan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study
- (2009) Srinivasan Dasarathy et al. JOURNAL OF HEPATOLOGY
- Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
- (2008) R. LOOMBA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now